We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04746924
Brief Title: A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

First Submitted : February 5, 2021
First Submitted that Met QC Criteria : February 5, 2021
First Posted : February 10, 2021

Last Update Submitted that Met QC Criteria : October 25, 2022
Last Update Posted : October 27, 2022